Principia Wealth Advisory, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Principia Wealth Advisory, LLC
- $118 Billion
- Q2 2025
A detailed history of Principia Wealth Advisory, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Principia Wealth Advisory, LLC holds 533,778 shares of EYPT stock, worth $6.33 Million. This represents 4.25% of its overall portfolio holdings.
Number of Shares
533,778
Previous 533,778
-0.0%
Holding current value
$6.33 Million
Previous $2.44 Billion
105.91%
% of portfolio
4.25%
Previous 2.34%
Shares
2 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
68.8MCall Options Held
421KPut Options Held
401K-
Cormorant Asset Management, LP Boston, MA8.33MShares$98.7 Million18.35% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.19MShares$73.4 Million2.57% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.56MShares$65.9 Million0.13% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.42MShares$52.3 Million0.12% of portfolio
-
Franklin Resources Inc San Mateo, CA4.17MShares$49.4 Million0.02% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $404M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...